Details

Autor(en) / Beteiligte

• Miah, Sayem
• Goel, Raghuveera Kumar
• Dai, Chenlu
• Kalra, Natasha
• Beaton-Brown, Erika
• Bagu, Edward T
• Bonham, Keith
• Lukong, Kiven E
• Gartel, Andrei L.

Titel

BRK targets Dok1 for ubiquitin-mediated proteasomal degradation to promote cell proliferation and migration

Ist Teil von

• PloS one, 2014-02, Vol.9 (2), p.e87684-e87684

Ort / Verlag

United States: Public Library of Science

Erscheinungsjahr

2014

Quelle

MEDLINE

Beschreibungen/Notizen

• Breast tumor kinase (BRK), also known as protein tyrosine kinase 6 (PTK6), is a non-receptor tyrosine kinase overexpressed in more that 60% of human breast carcinomas. The overexpression of BRK has been shown to sensitize mammary epithelial cells to mitogenic signaling and to promote cell proliferation and tumor formation. The molecular mechanisms of BRK have been unveiled by the identification and characterization of BRK target proteins. Downstream of tyrosine kinases 1 or Dok1 is a scaffolding protein and a substrate of several tyrosine kinases. Herein we show that BRK interacts with and phosphorylates Dok1 specifically on Y362. We demonstrate that this phosphorylation by BRK significantly downregulates Dok1 in a ubiquitin-proteasome-mediated mechanism. Together, these results suggest a novel mechanism of action of BRK in the promotion of tumor formation, which involves the targeting of tumor suppressor Dok1 for degradation through the ubiquitin proteasomal pathway.